The top 5 most-viewed heart failure (HF) content of the year focused on how walking can improve HF outcomes, a link between HF and carpal tunnel syndrome, and more.
Amgen has presented clinical data indicating that its PCSK9 inhibitor Repatha could help to reverse heart disease by removing atherosclerotic plaques, showing for the first time that the effect of this class of drugs may go further than reducing cholesterol alone. - News - PharmaTimes